Immunotherapy Monitoring

The development of methods to propagate immune T-cells, and in particular tumor specific T-cells from the patients with cancer, lead to an important breakthrough; the identification of MAGE-1,a melanoma-specific antigen that stimulates human T-cells in-vitro. With antigen specific T-cells as a reagents, it was possible to clone the MAGE-1 studies showed that the human immune system can respond tumor antigens, and the findings stimulated a productive effort to discover tumor antigens. The result is a long and still-growing list of antigens from a variety of tumor that could serve a variety of tumor’s that could serve as targets for treatment.

 

    Related Conference of Immunotherapy Monitoring

    November 21-22, 2019

    World Conference on Vaccine and Immunology

    MENA Plaza Hotel Albarsha | Dubai, UAE
    November 21-22, 2019

    14th International Conference on Allergy and Clinical Immunology

    Courtyard by Marriot Bali Seminyak Resort | Bali, Indonesia
    December 02-03, 2019

    10th International Conference on Immunology & Immunogenetics

    Park Inn by Radisson Hotel & Conference Centre London
    June 23-24, 2020

    34th World Congress on Vaccines and Immunization

    Osaka, Japan
    September 14-15, 2020

    35th World Congress on Immunology

    Tokyo, Japan
    Oct 12-13, 2020

    International Conference on Vaccine and Vaccine Research

    Manila, Philippines
    October 14-15, 2020

    13th International Conference on Allergy & Immunology

    Zurich, Switzerland
    October 19-20, 2020

    lifestylemanagment-cs-2020

    Amsterdam, Netherlands

    International Conference on Immunology & Immunotherapies

    November 18-19, 2020 | Bangkok, Thailand
    November 25-26, 2020

    International Conference On European Immunology

    London, UK

    Immunotherapy Monitoring Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in